3D Systems and Ekso Bionics(TM) Announce First "Bespoke" Exoskeleton
February 19 2014 - 6:33PM
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton
company, today announced that it recently debuted the first ever 3D
printed hybrid exoskeleton robotic suit, in collaboration with 3D
Systems (NYSE:DDD), at a Singularity University event in Budapest.
Designers from 3D Systems created personalized three-dimensional
elements from multiple 3D scans taken of Ekso Ambassador, Amanda
Boxtel.
"I believe that the most beautiful and functional designs have
already been patented by nature, and inspired by Amanda's
incredible spirit, we were able to harness nature's beauty with 3D
printed functionality and freedom of creation to allow her body and
spirit to soar," said Avi Reichental, President and CEO of 3DS.
"3DS has long been a pioneer in patient-specific devices,
integrating our cutting-edge 3D capabilities with robotics to
better serve humanity opens new and unimaginable frontiers."
The state of the art Ekso robot was integrated with 3D printed
components to create the first ever customized suit. "We are
pleased to partner with 3D Systems on pioneering work," said Russ
Angold, Ekso Bionics' Chief Technology Officer. "Our mission is to
redefine what's possible; Ekso has proven to be a compelling tool
for rehabilitation centers that have enabled thousands to walk in
EksoTM and Ekso GTTM. Collaborating with 3D Systems allows us to
experiment and look towards the future when custom exoskeletons for
individuals will be available."
Ekso Bionics designs, develops, and commercializes exoskeletons,
or wearable robots, which have a variety of applications in the
medical, military, industrial, and consumer markets. Exoskeletons
are ready-to-wear, battery-powered robots that are strapped over
the user's clothing, enabling individuals to achieve mobility,
strength, and endurance not otherwise possible. Ekso Bionics' lead
product, EksoTM, is a wearable bionics suit that enables
individuals with any amount of lower extremity weakness to stand up
and walk over ground. Ekso is forging a new frontier in
rehabilitation for people living with the consequences of stroke,
spinal cord injury and other neurological conditions affecting
gait.
About Ekso Bionics
Since 2005, Ekso Bionics (http://www.eksobionics.com) has been
pioneering the field of robotic exoskeletons, or wearable robots,
to augment human strength, endurance and mobility. The company's
first commercially available product called Ekso has helped
thousands of people living with paralysis take millions of steps
not otherwise possible. By designing and creating some of the most
forward-thinking and innovative solutions for people looking to
augment human capabilities, Ekso Bionics is helping people rethink
current physical limitations and achieve the remarkable.
Facebook: www.facebook.com/eksobionics Twitter: @eksobionics
YouTube: http://www.youtube.com/user/EksoBionics/
Forward-Looking
Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Forward-looking statements may include, without
limitation, statements regarding (i) the plans and objectives of
management for future operations, including plans or objectives
relating to the design, development and commercialization of human
exoskeletons, (ii) a projection of income (including income/loss),
earnings (including earnings/loss) per share, capital expenditures,
dividends, capital structure or other financial items, (iii) the
Company's future financial performance and (iv) the assumptions
underlying or relating to any statement described in points (i),
(ii) or (iii) above. Such forward-looking statements are not meant
to predict or guarantee actual results, performance, events or
circumstances and may not be realized because they are based upon
the Company's current projections, plans, objectives, beliefs,
expectations, estimates and assumptions and are subject to a number
of risks and uncertainties and other influences, many of which the
Company has no control over. Actual results and the timing of
certain events and circumstances may differ materially from those
described by the forward-looking statements as a result of these
risks and uncertainties. Factors that may influence or contribute
to the inaccuracy of the forward-looking statements or cause actual
results to differ materially from expected or desired results may
include, without limitation, the Company's inability to obtain
adequate financing, the significant length of time and resources
associated with the development of our products and related
insufficient cash flows and resulting illiquidity, the Company's
inability to expand the Company's business, significant government
regulation of medical devices and the healthcare industry, lack of
product diversification, volatility in the price of the Company's
raw materials, existing or increased competition, results of
arbitration and litigation, stock volatility and illiquidity, and
the Company's failure to implement the Company's business plans or
strategies. These and other factors are identified and described in
more detail in the Company's filings with the SEC, including, the
Company's Current Report on Form 8-K filed on January 23, 2014. The
Company does not undertake to update these forward-looking
statements.
CONTACT: Media Contact:
Heidi Darling, Marketing Manager
Phone: 415.302.4777
hdarling@eksobionics.com
Investor Contact:
Lauren Glaser, Vice President
Phone: 646.378.2972
lglaser@troutgroup.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Sep 2023 to Sep 2024